How Cell-Ag is funded
Cell-Ag currently earns no revenue. We are open to advertising and sponsorship, set out on our partnership page, and during the first year introductory advertising is carried at no charge. Advertising has no bearing on coverage. When that changes, this page will say so before it happens.
The editor's interests
The editor, Dr. Benjamin Zamanian, is Co-Founder and Chief Executive Officer of Technobiom, a cell-agriculture research and venture studio, and is involved in its cell-agriculture venture VitaPhilin Global. Cell-Ag covers the field those companies operate in. Any item that touches Technobiom or VitaPhilin, or a direct competitor of either, will carry that disclosure in the piece itself.
Gifts, travel and events
We pay our own travel, including factory and pilot-plant visits. Tasting samples are accepted only where refusing them would make the reporting impossible, and their source is stated in the piece. Gifts above nominal value are declined or donated, and the donation is recorded here.
Affiliate links
We use none. Links in stories are editorial and earn us nothing.
Questions
Anything unclear on this page is our fault, not yours. The rules behind these figures are in the editorial policy.